Gregory Babbitt
Associate Professor
Gregory Babbitt
Associate Professor
Education
BA, Ohio Wesleyan University; MS, Ph.D., University of Florida
Bio
I am a computational biologist with a focused interest in the development of modern statistical tools for comparative molecular dynamic simulation applied to the function and evolution of proteins and their interactions with other molecules in the cell. I am also broadly interested in the evolution of complex and stochastic biophysical process, across all scales, from the molecular to the ecological. For more information please visit my projects website.
Select Scholarship
Currently Teaching
In the News
-
September 14, 2021
New RIT visual modeling of coronavirus leads to discovery of behavior of second cellular ‘touchpoint’
WROC-TV features research by Gregory Babbitt, associate professor in the Thomas H. Gosnell School of Life Sciences; Patrick Rynkiewicz ’20 (bioinformatics and computational biology), ’21 MS (bioinformatics); Professor André Hudson, and Associate Professor Feng Cui.
-
August 17, 2021
RIT scientists model how coronavirus attaches itself to human cells
RIT scientists have uncovered new information about the way coronavirus and several of its variants attach to human cells. The researchers examined how coronaviruses use their spike proteins to attach themselves to the host cells they are attacking.
-
May 30, 2019
RIT student develops tool to visualize molecular dynamics of proteins in virtual reality
Kyle Diller, a fifth-year computer science student from East Windsor, N.J., developed a plug-in application for the molecular visualization program UCSF ChimeraX. The application is currently under development at the University of California at San Francisco. Diller’s plug-in allows users to display an atomic structure as if it were a movie so they can see how the structure changes.
-
April 28, 2022
School of Life Sciences team publishes paper in ‘Biophysical Reports’
-
July 28, 2021
Researchers publish paper on coronaviruses
-
June 25, 2021
Gregory Babbitt co-authors papers in ‘Elsevier’
-
April 26, 2021
Babbitt leads cancer drug study